A novel catheterization laboratory radiation shielding system: Results of pre-clinical testing.
Cardiovascular revascularization medicine : including molecular interventions
BACKGROUND: This pre-clinical study evaluated the efficacy of a novel shielding system to reduce scatter radiation in the cardiac catheterization laboratory.
METHODS: Using a scatter radiation phantom in a standard cardiac catheterization laboratory, a radiation physicist recorded radiation measurements at 20 reference points on the operator side of the table. Measurements were made with fluoroscopy and cine with the C-arm in the posterior-anterior (PA) and 40 degrees left anterior oblique (LAO) orientations. Scatter radiation doses were compared with and without use of the shielding system.
RESULTS: Use of the shielding system was associated with >94.2% reduction in scatter radiation across all reference points in the PA and LAO projections with fluoroscopy and cine. With the shielding system, dose reductions at the location of the primary operator ranged from 97.8% to 99.8%. At locations of maximum scatter radiation, use of the shielding system resulted in dose reductions ranging from 97.8% to 99.8% with fluoroscopy and from 97.9% to 99.8% with cine.
CONCLUSIONS: In this pre-clinical study, a novel radiation shielding system was observed to dramatically reduce scatter radiation doses. Based on these results, clinical testing is warranted to determine whether the shielding system will enable operators and staff to perform interventional procedures with less radiation exposure that may obviate the need to wear standard lead apparel.
INDEXING WORDS: Radiation safety; occupational health; occupational hazard.
Dixon SR, Rabah M, Emerson S, Schultz C, Madder RD. A novel catheterization laboratory radiation shielding system: results of pre-clinical testing. Cardiovasc Revasc Med. 2022 Mar;36:51-55. doi: 10.1016/j.carrev.2021.05.017. PMID: 34052128.